<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391859</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-1055</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Neuroscience insights</Title><ISOAbbreviation>Neurosci Insights</ISOAbbreviation></Journal><ArticleTitle>Recent Updates on COVID-19 Associated Strokes.</ArticleTitle><Pagination><StartPage>26331055241287730</StartPage><MedlinePgn>26331055241287730</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26331055241287730</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/26331055241287730</ELocationID><Abstract><AbstractText>The SARS-CoV-2 virus is primarily a respiratory virus, but, as it spread worldwide, it became apparent that there are multiple extrapulmonary manifestations. Reports arose of young and otherwise healthy patients presenting to emergency departments with large-vessel occlusions. Because of a rapidly evolving pandemic, conflicting data sometimes arose regarding the impact of the pandemic on strokes. COVID-19 can induce a hypercoagulable and a proinflammatory state through the interactions with the ACE-2 receptor. These mechanisms may lead to the strokes, both ischemic and hemorrhagic, that are seen in this infection. Strokes, in conjunction with COVID-19 infection, tended to be more disabling and portended a higher mortality. Treatment of these strokes was challenging, as emergency departments were strained with the high burden of COVID-19 admissions. Finally, vaccines against COVID-19 were widely administered, and their potential to cause stroke as an adverse event are discussed. This article will provide an in depth review of the recent updates about the incidence, epidemiology, pathophysiology, clinical presentation and treatment of strokes that are associated with COVID-19.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Betts</LastName><ForeName>Colton</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6649-761X</Identifier><AffiliationInfo><Affiliation>School of Medicine, Texas A&amp;M University Health Science Center, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahlfinger</LastName><ForeName>Zane</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-0595-3874</Identifier><AffiliationInfo><Affiliation>School of Medicine, Texas A&amp;M University Health Science Center, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udeh</LastName><ForeName>Mercy C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Texas A&amp;M University, College Station, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirmani</LastName><ForeName>Batool F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>School of Medicine, Texas A&amp;M University Health Science Center, Bryan, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, CHI St. Joseph Health, Bryan, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurosci Insights</MedlineTA><NlmUniqueID>101760670</NlmUniqueID><ISSNLinking>2633-1055</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391859</ArticleId><ArticleId IdType="pmc">PMC11465292</ArticleId><ArticleId IdType="doi">10.1177/26331055241287730</ArticleId><ArticleId IdType="pii">10.1177_26331055241287730</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Accessed November 27, 2023. Coronavirus disease (COVID-19) (who.int)</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson K, Tofiq A, Mathew A, et al.. Changes in stroke and TIA admissions during the COVID-19 pandemic: a meta-analysis. Eur Stroke J. 2024;9:78-87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10916820</ArticleId><ArticleId IdType="pubmed">37776062</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dusen RA, Abernethy K, Chaudhary N, Paudyal V, Kurmi O. Association of the COVID-19 pandemic on stroke admissions and treatment globally: a systematic review. BMJ Open. 2023;13:e062734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10030289</ArticleId><ArticleId IdType="pubmed">36931673</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegler JE, Abdalkader M, Michel P, Nguyen TN. Therapeutic trends of cerebrovascular disease during the COVID-19 pandemic and future perspectives. Stroke. 2022;24:179-188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9194541</ArticleId><ArticleId IdType="pubmed">35677974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke. 2021;16:137-149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022;269:1731-1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, Rodríguez-Gutiérrez R. Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis. Rev Neurosci. 2022;33:631-639.</Citation><ArticleIdList><ArticleId IdType="pubmed">35142148</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R, Best JG, Chandratheva A, Perry RJ, Werring DJ. Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data. J Neurol. 2021;268:3105-3115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864476</ArticleId><ArticleId IdType="pubmed">33547527</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, et al.. Acute ischemic stroke and COVID-19: an Aanalysis of 27 676 patients. Stroke. 2021;52:905-912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903982</ArticleId><ArticleId IdType="pubmed">33535779</ArticleId></ArticleIdList></Reference><Reference><Citation>Candeloro M, Schulman S. Arterial thrombotic events in hospitalized COVID-19 patients: a short review and meta-analysis. Semin Thromb Hemost. 2023;49:047-054.</Citation><ArticleIdList><ArticleId IdType="pubmed">35793687</ArticleId></ArticleIdList></Reference><Reference><Citation>Velissaris D, Michailides C, Karalis I, et al.. A literature review of pathophysiology, clinical manifestations, medications and optimal dosage, outpatient, and post-hospitalization use of anticoagulation in COVID-19 patients. Anatol J Cardiol. 2023;27:232-239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10160838</ArticleId><ArticleId IdType="pubmed">37119193</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres M, Moro MA, Nolte CH, et al.. Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke. Circ Res. 2022;130:1167-1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">35420915</ArticleId></ArticleIdList></Reference><Reference><Citation>May B, Wang DZ. Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management. Curr Opin Neurol. 2023;36:155-164.</Citation><ArticleIdList><ArticleId IdType="pubmed">36862014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc. 2020;95:1222-1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129862</ArticleId><ArticleId IdType="pubmed">32376099</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F, Nappi P, Gambardella I, Avtaar Singh SS. Thromboembolic disease and cardiac thrombotic complication in COVID-19: a systematic review. Metabolites. 2022;12:889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611930</ArticleId><ArticleId IdType="pubmed">36295791</ArticleId></ArticleIdList></Reference><Reference><Citation>Suprewicz Ł, Fiedoruk K, Czarnowska A, et al.. Blood-brain barrier function in response to SARS-CoV-2 and its spike protein. Neurol Neurochir Pol. 2023;57:14-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">36810757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Gillard Crewther S, Sales C, Karimi L. COVID-19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception-a systematic review. Front Neurol. 2020;11:607221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876298</ArticleId><ArticleId IdType="pubmed">33584506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci. 2022;21:77.</Citation><ArticleIdList><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Stilhano RS, Costa AJ, Nishino MS, et al.. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors. FASEB J. 2020;34:14103-14119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537138</ArticleId><ArticleId IdType="pubmed">32965736</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi S, Fifi JT, Ladner TR, et al.. Emergent large vessel occlusion stroke during New York City’s COVID-19 outbreak: clinical characteristics and paraclinical findings. Stroke. 2020;51:2656-2663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434004</ArticleId><ArticleId IdType="pubmed">32755349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrone SR, Sanmartin MX, Ohara J, et al.. Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis. J Neurointerv Surg. 2023;16:333-341.</Citation><ArticleIdList><ArticleId IdType="pubmed">37460215</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Abd-Allah F, Al-Senani F, et al.. Management of acute ischemic stroke in patients with COVID-19 infection: Insights from an international panel. Am J Emerg Med. 2020;38:1548.e5-1548.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211609</ArticleId><ArticleId IdType="pubmed">32444298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton E, Aladkhen J, O'Donnell C, et al.. Effects of the COVID-19 pandemic on prehospital emergency care for adults with stroke and transient ischaemic attack: a systematic review and meta-analysis. Prehosp Emerg Care. 2024;28:803-822.</Citation><ArticleIdList><ArticleId IdType="pubmed">37261801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawabi NLA, Duey AH, Kilgallon JL, et al.. Effects of the COVID-19 pandemic on stroke response times: a systematic review and meta-analysis. J Neurointerv Surg. 2022;14:642-649.</Citation><ArticleIdList><ArticleId IdType="pubmed">35387860</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Qushayri AE, Reda A, Dahy A, Azzam AY, Ghozy S. The impact of COVID 19 on the outcomes of thrombectomy in stroke patients: a systematic review and meta-analysis. Rev Med Virol. 2023;33:e2379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349746</ArticleId><ArticleId IdType="pubmed">35833712</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuckart I, Kabsha A, Siepmann T, Barlinn K, Barlinn J. Intravenous thrombolysis and endovascular therapy for acute ischemic stroke in COVID-19: a systematic review and meta-analysis. Front Neurol. 2023;14:1239953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482345</ArticleId><ArticleId IdType="pubmed">37681003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallas J, Wenger TA, Liu KQ, et al.. Mortality following mechanical thrombectomy for ischemic stroke in patients with COVID-19. J Stroke Cerebrovasc Dis. 2023;32:107171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10156987</ArticleId><ArticleId IdType="pubmed">37172468</ArticleId></ArticleIdList></Reference><Reference><Citation>Feler J, Chuck C, Anderson M, et al.. Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion. Interv Neuroradiol. 2023;29:540-547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10549714</ArticleId><ArticleId IdType="pubmed">35549746</ArticleId></ArticleIdList></Reference><Reference><Citation>Massoud GP, Hazimeh DH, Amin G, et al.. Risk of thromboembolic events in non-hospitalized COVID-19 patients: a systematic review. Eur J Pharmacol. 2023;941:175501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9833853</ArticleId><ArticleId IdType="pubmed">36641102</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Lee Y, Jehangir Q, et al.. SARS-COV-ATE risk assessment model for arterial thromboembolism in COVID-19. Sci Rep. 2022;12:16176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9516525</ArticleId><ArticleId IdType="pubmed">36171201</ArticleId></ArticleIdList></Reference><Reference><Citation>Flumignan RL, Civile VT, Tinôco JDDS, et al.. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022;2022:CD013739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8895460</ArticleId><ArticleId IdType="pubmed">35244208</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Covid-19 vaccination in the United States. 2022. Accessed October 10, 2022. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total</Citation></Reference><Reference><Citation>Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021;71:111-116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8272971</ArticleId><ArticleId IdType="pubmed">34330017</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver SE, Wallace M, See I, et al.. Use of the Janssen (Johnson &amp; Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices - United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022;71:90-95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8774160</ArticleId><ArticleId IdType="pubmed">35051137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta C, Perrone G, Adelfio V, et al.. COVID-19 vaccine-related thrombosis: a systematic review and exploratory analysis. Front Immunol. 2021;12:729251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666479</ArticleId><ArticleId IdType="pubmed">34912330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al.. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. 2021;428:117607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8330139</ArticleId><ArticleId IdType="pubmed">34365148</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43:3-40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557950</ArticleId><ArticleId IdType="pubmed">34719776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallone MG, Falcón AL, Castro HM, et al.. Thrombotic events following Covid-19 vaccines compared to influenza vaccines. Eur J Intern Med. 2022;99:82-88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8904150</ArticleId><ArticleId IdType="pubmed">35288031</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA. SARS-CoV-2 vaccines are not free of neurological side effects. Acta Neurol Scand. 2021;144:109-110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206845</ArticleId><ArticleId IdType="pubmed">34002379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahab F, Bayakly R, Sexton ME, et al.. Factors associated with stroke after COVID-19 vaccination: a statewide analysis. Front Neurol. 2023;14:1199745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337778</ArticleId><ArticleId IdType="pubmed">37448752</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas MG, Dermawan A, Teh S. Cerebellar and brainstem stroke possibly associated with booster dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. BMJ Case Rep. 2023;16:e251180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10163425</ArticleId><ArticleId IdType="pubmed">37147105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihle-Hansen H, Bøås H, Tapia G, et al.. Stroke after SARS-CoV-2 mRNA vaccine: a nationwide registry study. Stroke. 2023;54:E190-E193.</Citation><ArticleIdList><ArticleId IdType="pubmed">36994734</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama R, Fukuda K, Kouzaki Y, et al.. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta Neurochir. 2022;164:543-547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8594320</ArticleId><ArticleId IdType="pubmed">34783899</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>